| Diagnosis and management of hematological adverse events induced by immune checkpoint inhibitors: a systematic review NE Omar, KA El-Fass, AI Abushouk, N Elbaghdady, AEM Barakat, ... Frontiers in immunology 11, 531929, 2020 | 20 | 2020 |
| Effect of denosumab versus zoledronic acid on calcium levels in cancer patients with bone metastasis: A retrospective cohort study SM Nasser, A Sahal, A Hamad, S Elazzazy Journal of Oncology Pharmacy Practice 25 (8), 1846-1852, 2019 | 20 | 2019 |
| Postmarketing Safety of Anaplastic Lymphoma Kinase (ALK) Inhibitors: An Analysis of the FDA Adverse Event Reporting System (FAERS) AAA Omar N, Soliman A, Eshra M, Saeed T, Hamad A ESMO Open 6 (6), 100315, 2021 | 19 | 2021 |
| Risk of medication safety incidents with antibiotic use measured by defined daily doses A Hamad, G Cavell, P Wade, J Hinton, C Whittlesea International journal of clinical pharmacy 35 (5), 772-779, 2013 | 19 | 2013 |
| Perceptions and expectations of health care providers towards clinical pharmacy services at a tertiary cancer centre in Qatar NE Omar, S Elazzazy, O Abdallah, AJ Nashwan, Y Eltorki, HM Afifi, ... Journal of Oncology Pharmacy Practice 26 (5), 1086-1096, 2020 | 18 | 2020 |
| A pre–postintervention study to evaluate the impact of dose calculators on the accuracy of gentamicin and vancomycin initial doses A Hamad, G Cavell, J Hinton, P Wade, C Whittlesea BMJ open 5 (6), e006610, 2015 | 17 | 2015 |
| Overview of pharmacovigilance practices at the largest academic healthcare system in the State of Qatar M Al Hail, W Elkassem, A Hamad, P Abdulrouf, B Thomas, D Stewart International journal of clinical pharmacy 40 (4), 769-774, 2018 | 14 | 2018 |
| Operations Management of Outpatient Chemotherapy Process: An Optimization-Oriented Comprehensive Review M Hadid, A Elomri, T El Mekkawy, O Jouini, L Kerbache, A Hamad Operations Research Perspectives, 100214, 2021 | 13 | 2021 |
| Bibliometric analysis of cancer care operations management: current status, developments, and future directions M Hadid, A Elomri, T El Mekkawy, L Kerbache, A El Omri, H El Omri, ... Health Care Management Science 25 (1), 166-185, 2022 | 11 | 2022 |
| Efficacy and cost effectiveness of intravenous ferric carboxymaltose versus iron sucrose in adult patients with iron deficiency anaemia A Basha, MIM Ibrahim, A Hamad, P Chandra, NE Omar, MAJ Abdullah, ... PloS one 16 (8), e0255104, 2021 | 11 | 2021 |
| Assessment of Dasatinib Versus Nilotinib as Upfront Therapy for Chronic Phase of Chronic Myeloid Leukemia in Qatar: A Cost-Effectiveness Analysis A Adel, D Abushanab, A Hamad, M Abdulla, M Izham, M Yassin Cancer Control 28, 10732748211001796, 2021 | 11 | 2021 |
| Exploring job satisfaction among pharmacy professionals in the Arab world: a multi-country study AA Al-Jumaili, F Sherbeny, R Elhiny, B Hijazi, F Elbarbry, M Rahal, ... International Journal of Pharmacy Practice 30 (2), 160-168, 2022 | 10 | 2022 |
| Factors impacting job satisfaction among pharmacists in the Arab world: A qualitative study AA Al-Jumaili, R Elhiny, D Thomas, F Elbarbry, M Khdour, F Sherbeny, ... Saudi Pharmaceutical Journal 31 (4), 578-584, 2023 | 6 | 2023 |
| L-Glutamine and Crizanlizumab for Adults with Sickle Cell Disease (SCD) in Qatar: A Cost Effectiveness Analysis AA Adel, D Abushanab, A Hamad, D Al-Badriyeh, MA Yassin Blood 138, 4945, 2021 | 6 | 2021 |
| Dasatinib versus nilotinib as upfront therapy for treatment naïve chronic myeloid leukemia chronic phase MA Yassin, AA Hamad, RM Hussein, AM Basha, AM Adel, P Chandra, ... Medicine: Case Reports and Study Protocols 2 (2), e0061, 2021 | 5 | 2021 |
| Denosumab versus zoledronic acid for patients with beta-thalassemia major-induced osteoporosis MA Yassin, MOA Rahman, AA Hamad, AR Poil, MT Abdelrazek, ... Medicine 99 (51), e23637, 2020 | 5 | 2020 |
| Cost savings and cost avoidance with the inpatient clinical pharmacist interventions in a tertiary cancer care hospital D Abushanab, A Gulied, A Hamad, M Abu-Tineh, PV Abdul Rouf, ... Journal of Oncology Pharmacy Practice 29 (8), 1935-1943, 2023 | 4 | 2023 |
| Quantification of the growth suppression of HER2+ breast cancer colonies under the effect of trastuzumab and PD-1/PD-L1 inhibitor R Padmanabhan, H Kheraldine, I Gupta, N Meskin, A Hamad, S Vranic, ... Frontiers in Oncology 12, 977664, 2022 | 4 | 2022 |
| Clustering and Stochastic Simulation Optimization for Outpatient Chemotherapy Appointment Planning and Scheduling M Hadid, A Elomri, R Padmanabhan, L Kerbache, O Jouini, A El Omri, ... International Journal of Environmental Research and Public Health 19 (23), 15539, 2022 | 4 | 2022 |
| The Impact of Ethnicity on the Response to Eltrombopag in Patients With Immune Thrombocytopenia (ITP) in Qatar: A Single Institution Experience MA Yassin, R Ghasoub, A Soliman, O Ismail, AJ Nashwan, A Alshurafa, ... Cureus 14 (6), 2022 | 4 | 2022 |
Mohamed A . Yassin,MDProfessor of Hematology ,Head of Hematology ,Hamad Medical Corporation,CMED QUVerified email at hamad.qa
